Skip to content

Clinical trials

Phase 3 Pancreatic Neoplasms trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 3 Country / region: Austria Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20071
20081
20091
20111
20131
20142
20161
20171
20181
20192
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated5
Recruiting3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene2
Eli Lilly and Company2
Incyte Corporation2
Sanofi2
Amgen1
Arbeitsgemeinschaft medikamentoese Tumortherapie1
Arcus Biosciences, Inc.1
Elisabethinen Hospital1
Gilead Sciences1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms19
Neoplasms4
Endocrine Gland Neoplasms3
Neoplasm Metastasis3
Adenocarcinoma2
Digestive System Diseases2
Digestive System Neoplasms2
Endocrine System Diseases2
Neoplasms by Site2
Pancreatic Diseases2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.